Ingevity Statistics
Total Valuation
Ingevity has a market cap or net worth of $1.96 billion. The enterprise value is $3.26 billion.
Important Dates
The next confirmed earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ingevity has 36.47 million shares outstanding. The number of shares has increased by 0.34% in one year.
| Current Share Class | 36.47M |
| Shares Outstanding | 36.47M |
| Shares Change (YoY) | +0.34% |
| Shares Change (QoQ) | -0.55% |
| Owned by Insiders (%) | 0.76% |
| Owned by Institutions (%) | 102.82% |
| Float | 36.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.86 |
| PS Ratio | 1.48 |
| Forward PS | 1.46 |
| PB Ratio | 16.24 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.04 |
| P/OCF Ratio | 9.10 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.30, with an EV/FCF ratio of 21.68.
| EV / Earnings | n/a |
| EV / Sales | 2.46 |
| EV / EBITDA | 8.30 |
| EV / EBIT | 11.02 |
| EV / FCF | 21.68 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 11.40.
| Current Ratio | 1.36 |
| Quick Ratio | 0.71 |
| Debt / Equity | 11.40 |
| Debt / EBITDA | 3.32 |
| Debt / FCF | 9.15 |
| Interest Coverage | 3.26 |
Financial Efficiency
Return on equity (ROE) is -106.83% and return on invested capital (ROIC) is 11.05%.
| Return on Equity (ROE) | -106.83% |
| Return on Assets (ROA) | 8.90% |
| Return on Invested Capital (ROIC) | 11.05% |
| Return on Capital Employed (ROCE) | 19.92% |
| Revenue Per Employee | $828,000 |
| Profits Per Employee | -$135,375 |
| Employee Count | 1,600 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 3.21 |
Taxes
| Income Tax | -28.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.42% in the last 52 weeks. The beta is 1.41, so Ingevity's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | +50.42% |
| 50-Day Moving Average | 56.25 |
| 200-Day Moving Average | 46.29 |
| Relative Strength Index (RSI) | 43.15 |
| Average Volume (20 Days) | 175,774 |
Short Selling Information
The latest short interest is 929,966, so 2.55% of the outstanding shares have been sold short.
| Short Interest | 929,966 |
| Short Previous Month | 828,233 |
| Short % of Shares Out | 2.55% |
| Short % of Float | 2.57% |
| Short Ratio (days to cover) | 4.29 |
Income Statement
In the last 12 months, Ingevity had revenue of $1.32 billion and -$216.60 million in losses. Loss per share was -$5.96.
| Revenue | 1.32B |
| Gross Profit | 486.90M |
| Operating Income | 295.70M |
| Pretax Income | -245.00M |
| Net Income | -216.60M |
| EBITDA | 392.80M |
| EBIT | 295.70M |
| Loss Per Share | -$5.96 |
Full Income StatementBalance Sheet
The company has $76.90 million in cash and $1.38 billion in debt, giving a net cash position of -$1.30 billion or -$35.62 per share.
| Cash & Cash Equivalents | 76.90M |
| Total Debt | 1.38B |
| Net Cash | -1.30B |
| Net Cash Per Share | -$35.62 |
| Equity (Book Value) | 120.70M |
| Book Value Per Share | 3.31 |
| Working Capital | 142.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $215.40 million and capital expenditures -$65.10 million, giving a free cash flow of $150.30 million.
| Operating Cash Flow | 215.40M |
| Capital Expenditures | -65.10M |
| Free Cash Flow | 150.30M |
| FCF Per Share | $4.12 |
Full Cash Flow StatementMargins
Gross margin is 36.75%, with operating and profit margins of 22.32% and -16.35%.
| Gross Margin | 36.75% |
| Operating Margin | 22.32% |
| Pretax Margin | -18.49% |
| Profit Margin | -16.35% |
| EBITDA Margin | 29.65% |
| EBIT Margin | 22.32% |
| FCF Margin | 11.35% |
Dividends & Yields
Ingevity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.34% |
| Shareholder Yield | -0.34% |
| Earnings Yield | -11.05% |
| FCF Yield | 7.67% |
Dividend DetailsAnalyst Forecast
The average price target for Ingevity is $58.00, which is 7.89% higher than the current price. The consensus rating is "Buy".
| Price Target | $58.00 |
| Price Target Difference | 7.89% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ingevity has an Altman Z-Score of 2.16 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.16 |
| Piotroski F-Score | 6 |
